ArticleFuture oncology (London, England)2025

REGAL: galinpepimut-S vs. best available therapy as maintenance therapy for acute myeloid leukemia in second remission.

Omer Jamy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.